Both in Pharmaceuticals
Roivant Sciences vs Insmed
Over the past year ROIV returned +94.9% and INSM returned −40.9%; their daily moves had a correlation of 0.24.
ROIV +94.9% INSM −40.9%Growth of $1, one year, split-adjusted
| Metric | ROIV | INSM |
|---|---|---|
| Price | $36.66 | $97.01 |
| Market cap | $26.48B | $21.18B |
| Today | +0.33% | +2.15% |
| 1 month | +0.4% | −16.1% |
| 6 months | +33.2% | −28.2% |
| Year to date | +68.9% | −44.3% |
| 1 year | +94.9% | −40.9% |
| Revenue growth (YoY) | −33.5% | +296.1% |
| Gross margin | 100.0% | 84.2% |
| Net margin | −13164.8% | −3.1% |
| P/E (TTM) | — | — |
| Price / sales | 3,515.7× | 18.6× |
| Net cash | $3.84B | $594.4M |
| Dividend yield | — | — |
| Volatility (60d) | 49.0% | 70.3% |
| Short % of float | 8.0% | 6.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).